Surgery for hidden lung cancer spread: a new hope for longer life?
NCT ID NCT06547710
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This trial looks at whether surgically removing the primary lung tumor can help people with M1a stage lung cancer, where cancer cells are found in the chest lining during surgery. The study includes 66 adults aged 18–80 who have not had prior lung cancer treatment. Researchers will measure overall survival and quality of life to see if the surgery offers benefit.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- surgical removal of the primary lung tumor
- What this could lead to
- If successful, this could show that removing the main tumor improves survival and quality of life for patients with lung cancer that has spread to the chest lining.
- What could go wrong
- This is an early-phase trial with only 66 participants, so results may not apply to everyone. Surgery carries risks like infection or breathing problems, and the cancer may still progress.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tiny implant trap brain tumor cells and make radiation work better?
- Can zapping a few spots keep lung cancer in check?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- New drug combo aims to outperform standard care in aggressive lung cancer
- Could a cholesterol drug boost immunotherapy in lung cancer?
- Scientists hunt for clues to why immunotherapy fails in most patients